BMC Cancer
- CHAI H, Pan C, Zhang M, Huo H, et al
Retraction Note: Histone methyltransferase SETD1A interacts with notch and
promotes notch transactivation to augment ovarian cancer development.
BMC Cancer. 2026;26:984.
- HACHISUGA K, Katayama Y, Inomata Y, Kawakami M, et al
Tumor immune microenvironment and epithelial-mesenchymal transition in recurrence
of low-grade stage IA endometrial endometrioid carcinoma.
BMC Cancer. 2026 Jun 2. doi: 10.1186/s12885-026-16277.
Eur J Obstet Gynecol Reprod Biol
- BAHCECI P, Ay O, Energin H
Clinicopathologic prognostic factors and the role of adenomyosis in endometrial
cancer: A 25-year single-center experience.
Eur J Obstet Gynecol Reprod Biol. 2026;325:115284.
Int J Gynecol Pathol
- HELLBERG P, Pasanen A, Simila-Maarala J, Butzow R, et al
p53 Normal and p53 Abnormal Clear Cell Ovarian Carcinomas: Clinical
Characteristics and Biomarker Profiles.
Int J Gynecol Pathol. 2026;45:340-348.
- ALZAYADNEH E, Dibbern ME, Rabban J, Fadare O, et al
HER2 and FOLR1 Expression in Mesonephric and Mesonephric-Like Adenocarcinomas in
the Gynecologic Tract.
Int J Gynecol Pathol. 2026;45:349-357.
- CHEN Q, Wei Z, Tang F
Collision Tumor of the Uterine Corpus: Primary EBV-positive Diffuse Large B-Cell
Lymphoma and Endometrioid Carcinoma.
Int J Gynecol Pathol. 2026;45:412-417.
Oncogene
- GUILBARD M, Taouji S, Aubry M, Robert J, et al
Complementary intra- and extracellular AGR2 activities support epithelial ovarian
cancer cell aggressiveness.
Oncogene. 2026 Aug 10. doi: 10.1038/s41388-026-03938.
PLoS One
- MAJUMDER R, Datta P, Moolayadukkam S, Puri IK, et al
Repurposing Alzheimer's and ovarian cancer drugs as sonosensitizers for
glioblastoma via a positive-unlabeled learning and 3D bioprinting-based new
approach methodology (NAM).
PLoS One. 2026;21:e0354981.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016